Product Name

  • Name

    Buspirone hydrochloride

  • EINECS 251-489-4
  • CAS No. 33386-08-2
  • Article Data6
  • CAS DataBase
  • Density 1.24g/cm3
  • Solubility Soluble in methanol (50 mg/ml), water (partly), DMSO (100 mM).
  • Melting Point 201.5-202.5 °C
  • Formula C21H31N5O2.HCl
  • Boiling Point 613.9 °C at 760 mmHg
  • Molecular Weight 421.97
  • Flash Point 325.1 °C
  • Transport Information UN 2811 6.1/PG 3
  • Appearance white solid
  • Safety 45-36-26
  • Risk Codes 25-36/37/38-20/21/22
  • Molecular Structure Molecular Structure of 33386-08-2 (Buspirone hydrochloride)
  • Hazard Symbols ToxicT, HarmfulXn
  • Synonyms 1,1-Cyclopentanediacetimide,N-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, monohydrochloride (8CI);8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-,monohydrochloride (9CI);8-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dionehydrochloride;Ansial;Ansiced;Ansiten;Axoren;Bespar;Buscalma;Buspa;Buspar;Buspimem;Buspinol;Buspirone hydrochloride;Buspironemonohydrochloride;Buspisal;Busron;Censpar;Lucelan;MJ 9022-1;Narol;Travin;
  • PSA 69.64000
  • LogP 2.83100

Buspirone hydrochloride Specification

The IUPAC name of Buspirone hydrochloride is 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride. With the CAS registry number 33386-08-2, it is also named as 1,1-Cyclopentanediacetimide, N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, hydrochloride. The product's categories are Intermediates & Fine Chemicals; Pharmaceuticals; Serotonin Receptor. Besides, it is white solid, which should be sealed at 2-8 °C. This chemical is used as a receptor agonist of 5-Hydroxytryptamine. In addition, its molecular formula is C21H31N5O2.HCl and molecular weight is 421.96.

The other characteristics Buspirone hydrochloride can be summarized as: (1)EINECS: 251-489-4; (2)ACD/LogP: 3.43; (3)# of Rule of 5 Violations: 0; (4)ACD/LogD (pH 5.5): 2.26; (5)ACD/LogD (pH 7.4): 3.37; (6)ACD/BCF (pH 5.5): 16.18; (7)ACD/BCF (pH 7.4): 205.29; (8)ACD/KOC (pH 5.5): 118.63; (9)ACD/KOC (pH 7.4): 1504.97; (10)#H bond acceptors: 7; (11)#H bond donors: 0; (12)#Freely Rotating Bonds: 6; (13)Polar Surface Area: 69.64 Å2; (14)Flash Point: 325.1 °C; (15)Melting Point: 201.5-202.5 °C; (16)Enthalpy of Vaporization: 91.11 kJ/mol; (17)Boiling Point: 613.9 °C at 760 mmHg; (18)Vapour Pressure: 5.24E-15 mmHg at 25 °C.

When you are using this chemical, please be cautious about it as the following: it is harmful and toxic by inhalation, in contact with skin and if swallowed. It is also irritating to eyes, respiratory system and skin. In case of contact with eyes, please rinse immediately with plenty of water and seek medical advice. And you should wear suitable protective clothing. Moreover, in case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)

People can use the following data to convert to the molecule structure.
(1)SMILES: Cl.O=C1N(C(=O)CC2(C1)CCCC2)CCCCN4CCN(c3ncccn3)CC4
(2)InChI: InChI=1/C21H31N5O2.ClH/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20;/h5,8-9H,1-4,6-7,10-17H2;1H
(3)InChIKey: RICLFGYGYQXUFH-UHFFFAOYAP

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 oral 586mg/kg (586mg/kg)   Medicamentos de Actualidad. Vol. 23, Pg. 311, 1987.
human TDLo oral 285ug/kg (0.285mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"

SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE
Clinical Pharmacology and Therapeutics Vol. 57, Pg. 349, 1995.
mammal (species unspecified) LD50 unreported 140mg/kg (140mg/kg)   Pharmaceutical Chemistry Journal Vol. 25, Pg. 193, 1991.
man TDLo oral 4mg/kg/2W-I (4mg/kg) BEHAVIORAL: EUPHORIA British Journal of Psychiatry. Vol. 158, Pg. 136, 1991.
monkey LD50 oral 356mg/kg (356mg/kg)   Medicamentos de Actualidad. Vol. 23, Pg. 311, 1987.
mouse LD50 intraperitoneal 146mg/kg (146mg/kg) BEHAVIORAL: ANTIPSYCHOTIC

BEHAVIORAL: ALTERATION OF CLASSICAL CONDITIONING
Journal of Medicinal Chemistry. Vol. 15, Pg. 477, 1972.
mouse LD50 oral 655mg/kg (655mg/kg)   Medicamentos de Actualidad. Vol. 23, Pg. 311, 1987.
rat LD50 intraperitoneal 136mg/kg (136mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 917, 1974.
rat LD50 oral 196mg/kg (196mg/kg)   Medicamentos de Actualidad. Vol. 23, Pg. 311, 1987.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View